Safety and preliminary efficacy of allogeneic umbilical cord-derived mesenchymal stem cells administered via the hepatic artery in patients with liver cirrhosis: A phase I open-label trial.
Saved in:
| Title: | Safety and preliminary efficacy of allogeneic umbilical cord-derived mesenchymal stem cells administered via the hepatic artery in patients with liver cirrhosis: A phase I open-label trial. |
|---|---|
| Authors: | Nguyen LT; Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), College of Health Sciences, VinUniversity, Hanoi, Vietnam.; Vinmec Times City International Hospital, Vinmec Healthcare System, Hanoi, Vietnam., Nguyen HP; Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), College of Health Sciences, VinUniversity, Hanoi, Vietnam., Bui HT; Vinmec Times City International Hospital, Vinmec Healthcare System, Hanoi, Vietnam., Nguyen QT; Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), College of Health Sciences, VinUniversity, Hanoi, Vietnam., Nguyen PV; Vinmec Times City International Hospital, Vinmec Healthcare System, Hanoi, Vietnam., Ha HTT; Vinmec Times City International Hospital, Vinmec Healthcare System, Hanoi, Vietnam. |
| Source: | Cell transplantation [Cell Transplant] 2026 Jan-Dec; Vol. 35, pp. 9636897261449975. Date of Electronic Publication: 2026 May 26. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9208854 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-3892 (Electronic) Linking ISSN: 09636897 NLM ISO Abbreviation: Cell Transplant Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
